Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Frank Culotta (NPI 1659335545)

Field	Value
Entity Type	Individual
Organization	Frank Culotta
Address	1101 S College Rd
City	Lafayette
State	LA
ZIP	70503
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 17, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider has reported $1.7M in total Medicare revenue and no Medicaid billing on file, making the practice effectively single-payer (Medicare) in scale. The NPI was enumerated 2006-04-17 (~20 years ago), indicating a long-tenured practice that is likely established in the Lafayette, LA market and in Medicare billing patterns.

Revenue is heavily concentrated in a small set of intravitreal drug codes: the precomputed top 3 Medicare codes account for 62.9% of this provider's total Medicare revenue, driven by J0178 (40.5%), J2777 (15.7%), and J2781 (6.6%). This concentration signals that clinic revenue is dependent on biologic injectable therapies commonly used in retina practice rather than broad primary-care E/M volume.

The CPT/HCPCS mix is consistent with a retina-focused specialty practice: high-volume intravitreal injections (J0178 1K claims, $714.1K revenue; J2777 9.5K claims, $276.7K revenue; J2781 975 claims, $117K revenue), implant codes (J7312 $85.7K, J7314 $81.4K) and retina imaging (92134 1.9K claims, $52.5K revenue) appear prominently. Presence of surgical vitreoretinal codes such as 67028 (829 claims, $77.1K revenue), 67036 and 67042 indicates the provider performs procedural and operative retina work in addition to injections.

For the leading injection products, the provider’s national competitive standing is mixed: J0178 ranks #1253 of 3204 providers nationally (61th percentile; typical, unremarkable volume) and J2777 ranks #1040 of 2039 providers nationally (49th percentile; typical, unremarkable volume), while J2781 ranks #124 of 490 providers nationally (75th percentile; typical, unremarkable volume). In plain terms, the provider is a modest/typical national participant for aflibercept and faricimab use but shows relatively stronger utilization of pegcetacoplan compared with peers.

Several non-drug codes show notably above-typical volume for the specialty: 92014 (1.3K claims, $108.4K revenue) ranks #905 of 35415 providers nationally (97th percentile; notably above typical national volume), 92134 ranks #1155 of 26868 (96th percentile; notably above typical national volume), and J7312 ranks #31 of 492 (94th percentile; notably above typical national volume). These high percentiles for E/M, imaging, and implant codes suggest robust diagnostic throughput and follow-up/implant management relative to national peers.

There are a few unusual utilization signatures worth flagging for review: J2403 shows 50.4K claims with $1 avg paid/claim for $50.4K total revenue and ranks #51 of 76 providers nationally (33th percentile), reflecting very high claim volume at a low unit payment. Additionally, limited-count unclassified drug codes such as J3490 (35 claims, $61.9K revenue, $1768 avg paid/claim) and J3590 (20 claims, $42.4K revenue, $2120 avg paid/claim) indicate occasional high-dollar billed items that contribute materially to revenue despite low claim counts.

Surgical retinal procedures contribute to revenue but at a smaller share relative to injections and imaging: 67028 ($77.1K revenue), 67036 ($13.5K revenue), and 67042 ($25.8K revenue) are present at typical national volumes (ratings ranging from typical to modestly above typical). This pattern is consistent with a retina specialist who balances clinic-based intravitreal therapy and diagnostics with a non-dominant but present surgical practice.

For payer and provider analysts, key implications are clear: dependency on Medicare ($1.7M vs. no Medicaid) and concentration of revenue in injectable biologics (top 3 = 62.9%) create exposure to shifts in drug utilization, reimbursement policy, or formulary preferences. The provider’s long tenure since 2006 and high percentiles on imaging and certain E/M codes suggest an established referral base and operational capacity in retina diagnostics and follow-up care, but monitoring of high-frequency low-unit codes and occasional high-dollar unclassified drug billing is warranted for contract and utilization reviews.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,040	$690	$714.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,540	$30	$276.7K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	980	$120	$117K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,290	$80	$108.4K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	560	$150	$85.7K
J7314	Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg	200	$410	$81.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	830	$90	$77.1K
J3490	Unclassified drugs	40	$1,770	$61.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,880	$30	$52.5K
J2403	Chloroprocaine hcl ophthalmic, 3% gel, 1 mg	50,400	$1	$50.4K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Frank Culotta — 4 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	9	50	300	$680	$371.5K
J2777	10	30	6,660	$30	$309.4K
J3590	5	10	70	$490	$92K
J2781	2	10	830	$120	$86K
J7314	1	10	200	$410	$81.3K
J3490	13	20	50	$620	$49.1K
J2403	4	10	50,400	$1	$45.5K
67028	15	70	410	$80	$44.3K
J7312	1	10	200	$150	$39.1K
67042	4	20	20	$1,110	$26.6K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Frank Culotta, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
Shanda Jackson	LA	Family Nurse Practitioner	$4M	$0
James Russo	LA	Radiation Oncology Physician	$3.5M	$0
Stephen Price	LA	Physician Assistant	$3.4M	$0
Jyothi Mallepalli	LA	Rheumatology Physician	$3.2M	$0
Kirtan Koticha	LA	Hematology & Oncology Physician	$3.1M	$0
Russell Fileccia	LA	Cardiovascular Disease Physician	$2.6M	$0
Ruben Grigorian	LA	Ophthalmology Physician	$2.4M	$57.1K
Jeffrey Gosslee	LA	Retina Specialist (Ophthalmology) Physician	$2.3M	$4.5K
Jonathan Perkins	LA	Retina Specialist (Ophthalmology) Physician	$1.7M	$160.4K

Nearby Providers

Other providers in the same ZIP code as Frank Culotta, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Merakey Pennsylvania	LA	Community/Behavioral Health Agency	$0	$37.7M
Lafayette General Medical Center Inc	LA	General Acute Care Hospital	$0	$31.1M
New Day Personal Care Services	LA	In Home Supportive Care Agency	$0	$28.5M
Gulf Coast Teaching Family Services, Inc.	LA	Community/Behavioral Health Agency	$0	$13.1M
Coolidge Emergency Group LLC	LA	Emergency Medicine Physician	$0	$11.1M
Pediatrust Acadiana, LLC	LA	Medically Fragile Infants and Children Day Care	$0	$8.6M
Critical Care Newborn Services	LA	Neonatal-Perinatal Medicine Physician	$0	$7.6M
New Day Personal Care Services	LA	In Home Supportive Care Agency	$0	$6.9M
A Blessing Personal Home Care	LA	In Home Supportive Care Agency	$0	$6.4M
Priority Medical Care Inc.	LA	Home Health Agency	$0	$6.2M

Frank Culotta — Billing Profile & Reimbursement Data

Sign up for Frank Culotta — Billing Profile & Reimbursement Data policy alerts

Frank Culotta — Billing Profile & Reimbursement Data

Sign up for Frank Culotta — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References